Researchers publishing in the Journal of Clinical Psychiatry argue that broadening the diagnostic criteria for bipolar disorder would result in a greater increase in “false positives” than in “true” diagnoses, while there are no controlled studies demonstrating the efficacy of mood stabilizers in treating “subthreshold” bipolar disorder. They also assert that an increase in “false positive” diagnoses would go undetected because the absence of future manic/hypomanic episodes would “incorrectly be considered evidence of the efficacy of treatment, and the unnecessary medications that might cause medically significant side effects would not be discontinued.”
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.